173 related articles for article (PubMed ID: 16285908)
1. Micro-PET/CT monitoring of herpes thymidine kinase suicide gene therapy in a prostate cancer xenograft: the advantage of a cell-specific transcriptional targeting approach.
Johnson M; Sato M; Burton J; Gambhir SS; Carey M; Wu L
Mol Imaging; 2005; 4(4):463-72. PubMed ID: 16285908
[TBL] [Abstract][Full Text] [Related]
2. CL1-SR39: A noninvasive molecular imaging model of prostate cancer suicide gene therapy using positron emission tomography.
Pantuck AJ; Berger F; Zisman A; Nguyen D; Tso CL; Matherly J; Gambhir SS; Belldegrun AS
J Urol; 2002 Sep; 168(3):1193-8. PubMed ID: 12187266
[TBL] [Abstract][Full Text] [Related]
3. Monitoring the efficacy of adoptively transferred prostate cancer-targeted human T lymphocytes with PET and bioluminescence imaging.
Dobrenkov K; Olszewska M; Likar Y; Shenker L; Gunset G; Cai S; Pillarsetty N; Hricak H; Sadelain M; Ponomarev V
J Nucl Med; 2008 Jul; 49(7):1162-70. PubMed ID: 18552144
[TBL] [Abstract][Full Text] [Related]
4. Configurations of a two-tiered amplified gene expression system in adenoviral vectors designed to improve the specificity of in vivo prostate cancer imaging.
Sato M; Figueiredo ML; Burton JB; Johnson M; Chen M; Powell R; Gambhir SS; Carey M; Wu L
Gene Ther; 2008 Apr; 15(8):583-93. PubMed ID: 18305574
[TBL] [Abstract][Full Text] [Related]
5. Thymidine Kinase PET Reporter Gene Imaging of Cancer Cells In Vivo.
McCracken MN
Methods Mol Biol; 2018; 1790():137-151. PubMed ID: 29858789
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus-mediated suicide-gene therapy using the herpes simplex virus thymidine kinase gene in cell and animal models of human prostate cancer: changes in tumour cell proliferative activity.
Cheon J; Kim HK; Moon DG; Yoon DK; Cho JH; Koh SK
BJU Int; 2000 Apr; 85(6):759-66. PubMed ID: 10759680
[TBL] [Abstract][Full Text] [Related]
7. Optimizing prostate cancer suicide gene therapy using herpes simplex virus thymidine kinase active site variants.
Pantuck AJ; Matherly J; Zisman A; Nguyen D; Berger F; Gambhir SS; Black ME; Belldegrun A; Wu L
Hum Gene Ther; 2002 May; 13(7):777-89. PubMed ID: 11975845
[TBL] [Abstract][Full Text] [Related]
8. MicroPET imaging of prostate cancer in LNCAP-SR39TK-GFP mouse xenografts.
Yang H; Berger F; Tran C; Gambhir SS; Sawyers CL
Prostate; 2003 Apr; 55(1):39-47. PubMed ID: 12640659
[TBL] [Abstract][Full Text] [Related]
9. Treatment efficiency of a suicide gene therapy using prostate-specific membrane antigen promoter/enhancer in a castrated mouse model of prostate cancer.
Ikegami S; Tadakuma T; Ono T; Suzuki S; Yoshimura I; Asano T; Hayakawa M
Cancer Sci; 2004 Apr; 95(4):367-70. PubMed ID: 15072597
[TBL] [Abstract][Full Text] [Related]
10. Osteonectin Promoter-Mediated Suicide Gene Therapy of Prostate Cancer.
Hsiao WC; Sung SY; Chung LWK; Hsieh CL
Methods Mol Biol; 2019; 1895():27-42. PubMed ID: 30539527
[TBL] [Abstract][Full Text] [Related]
11. Functionality of androgen receptor-based gene expression imaging in hormone refractory prostate cancer.
Sato M; Johnson M; Zhang L; Gambhir SS; Carey M; Wu L
Clin Cancer Res; 2005 May; 11(10):3743-9. PubMed ID: 15897571
[TBL] [Abstract][Full Text] [Related]
12. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
[TBL] [Abstract][Full Text] [Related]
13. Imaging progress of herpes simplex virus type 1 thymidine kinase suicide gene therapy in living subjects with positron emission tomography.
Yaghoubi SS; Barrio JR; Namavari M; Satyamurthy N; Phelps ME; Herschman HR; Gambhir SS
Cancer Gene Ther; 2005 Mar; 12(3):329-39. PubMed ID: 15592447
[TBL] [Abstract][Full Text] [Related]
14. Imaging chemically modified adenovirus for targeting tumors expressing integrin alphavbeta3 in living mice with mutant herpes simplex virus type 1 thymidine kinase PET reporter gene.
Xiong Z; Cheng Z; Zhang X; Patel M; Wu JC; Gambhir SS; Chen X
J Nucl Med; 2006 Jan; 47(1):130-9. PubMed ID: 16391197
[TBL] [Abstract][Full Text] [Related]
15. Co-Targeting Prostate Cancer Epithelium and Bone Stroma by Human Osteonectin-Promoter-Mediated Suicide Gene Therapy Effectively Inhibits Androgen-Independent Prostate Cancer Growth.
Sung SY; Chang JL; Chen KC; Yeh SD; Liu YR; Su YH; Hsueh CY; Chung LW; Hsieh CL
PLoS One; 2016; 11(4):e0153350. PubMed ID: 27054343
[TBL] [Abstract][Full Text] [Related]
16. Improved herpes simplex virus type 1 amplicon vectors for proportional coexpression of positron emission tomography marker and therapeutic genes.
Jacobs AH; Winkeler A; Hartung M; Slack M; Dittmar C; Kummer C; Knoess C; Galldiks N; Vollmar S; Wienhard K; Heiss WD
Hum Gene Ther; 2003 Feb; 14(3):277-97. PubMed ID: 12639307
[TBL] [Abstract][Full Text] [Related]
17. Optimization of adenoviral vectors to direct highly amplified prostate-specific expression for imaging and gene therapy.
Sato M; Johnson M; Zhang L; Zhang B; Le K; Gambhir SS; Carey M; Wu L
Mol Ther; 2003 Nov; 8(5):726-37. PubMed ID: 14599805
[TBL] [Abstract][Full Text] [Related]
18. Titration of variant HSV1-tk gene expression to determine the sensitivity of 18F-FHBG PET imaging in a prostate tumor.
Johnson M; Karanikolas BD; Priceman SJ; Powell R; Black ME; Wu HM; Czernin J; Huang SC; Wu L
J Nucl Med; 2009 May; 50(5):757-64. PubMed ID: 19372484
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional targeting of virus-mediated gene transfer by the human hexokinase II promoter.
Määttä AM; Korja S; Venhoranta H; Hakkarainen T; Pirinen E; Heikkinen S; Pellinen R; Mäkinen K; Wahlfors J
Int J Mol Med; 2006 Nov; 18(5):901-8. PubMed ID: 17016620
[TBL] [Abstract][Full Text] [Related]
20. Cancer suicide gene therapy with TK.007: superior killing efficiency and bystander effect.
Preuss E; Muik A; Weber K; Otte J; von Laer D; Fehse B
J Mol Med (Berl); 2011 Nov; 89(11):1113-24. PubMed ID: 21698427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
